KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Inventory (2016 - 2025)

Historic Inventory for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $53.2 million.

  • Pacific Biosciences Of California's Inventory fell 1914.29% to $53.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.2 million, marking a year-over-year decrease of 1914.29%. This contributed to the annual value of $58.8 million for FY2024, which is 366.82% up from last year.
  • As of Q3 2025, Pacific Biosciences Of California's Inventory stood at $53.2 million, which was down 1914.29% from $53.8 million recorded in Q2 2025.
  • Pacific Biosciences Of California's 5-year Inventory high stood at $68.6 million for Q2 2024, and its period low was $16.3 million during Q1 2021.
  • Over the past 5 years, Pacific Biosciences Of California's median Inventory value was $53.8 million (recorded in 2025), while the average stood at $48.0 million.
  • As far as peak fluctuations go, Pacific Biosciences Of California's Inventory soared by 13798.97% in 2022, and later tumbled by 2151.06% in 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Inventory (Quarter) stood at $24.6 million in 2021, then soared by 104.81% to $50.4 million in 2022, then increased by 12.49% to $56.7 million in 2023, then grew by 3.67% to $58.8 million in 2024, then decreased by 9.53% to $53.2 million in 2025.
  • Its Inventory stands at $53.2 million for Q3 2025, versus $53.8 million for Q2 2025 and $54.0 million for Q1 2025.